Psychedelic Medicine
Association
Psychedelic
Medicine
Association

President, Psychedelic Medicine Association

Co-Founder, Psychedelics Today & Vital
Kyle Buller is the co-founder of Psychedelics Today, a leading psychedelic media and education company. Inspired by a near-death snowboarding accident at 16, Kyle pursued a B.A. in Transpersonal Psychology and an M.S. in Clinical Mental Health Counseling with a focus on somatic psychology. He specializes in psychedelic integration, spiritual emergence, and breathwork. Kyle is also a breathwork facilitator and has studied Dreamshadow Transpersonal Breathwork since 2010.

Clinical Director & Co-Founder, Alchemy Community Therapy Center
Irina Alexander is a Co-Founder and Clinical Director of Alchemy Community Therapy Center, a sliding scale psychedelic therapy clinic in Oakland, as well as a street-based harm reduction therapist with the Harm Reduction Therapy Center in San Francisco. Irina has a long history in direct service work, and believes in the healing capacity of showing up for each other, individually and as a community. She feels passionate about making psychedelic healing services more equitable and accessible to underserved communities. Irina has volunteered for several years as a supervisor with the Zendo Project, and has worked as an Adherence Rater for MDMA Clinical Trials since 2017.

Founder & CEO, Kaivalya Kollectiv & Tandava Retreats; Co-Founder, F.I.V.E.
Joël Brierre has a strong background in the Yogic traditions and has been teaching these practices for nearly two decades. His unique approach of applying classical non-dual yogic philosophy for both the preparation and integration of the 5-MeO-DMT experience, and from the entheogenic experience is deeply relevant to navigating these states of consciousness and the landscape of psychedelic use. Joel is the founder & CEO of Tandava Retreats as well as CEO and Co-founder of F.I.V.E. (5-MeO-DMT Information and Vital Education). Joel integrates the history of 5-MeO-DMT and modern integrative practices into every aspect of the retreat experience.

Chief Medical Officer at Novamind/Co-founder at Cedar Psychiatry
Dr. Reid Robison is a board-certified psychiatrist and Chief Medical Officer at Novamind. Reid is co-founder at Cedar Psychiatry and serves as Medical Director of Center for Change, a top Eating Disorder program. He is currently the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad.
As psychedelics become increasingly integrated into the medical mainstream, practitioners across various fields may be eager to learn how to engage with this emerging area of treatment. At a fundamental level, clinicians can begin by educating themselves about psychedelics and sharing their insights with patients. However, once they discover the effectiveness and transformative potential of psychedelic therapies, many seek to become more actively involved.
For instance, we frequently receive inquiries in our forums from members asking about the best pathways to become psychedelic-assisted therapists or facilitators. Additionally, there is significant interest in which training programs are most beneficial.
To address these questions, we will be dedicating some of our upcoming monthly webinars to explore training programs and other relevant topics for those looking to deepen their involvement in psychedelic therapies.
…and much more!
As always, there will be ample time for audience Q&A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Tuesday, April 29th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.